IGLC1
Immunoglobulin lambda constant 1
Also known as: IGLC1_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- P0CG04
- Gene
- IGLC1
- Canonical length
- 106 aa
- Protein class
- Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins
OverviewNCBI Gene
No narrative summary is available for IGLC1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
106 residues, UniProt reviewed canonical sequence.
>P0CG04|IGLC1
1 GQPKANPTVT LFPPSSEELQ ANKATLVCLI SDFYPGAVTV AWKADGSPVK AGVETTKPSK
61 QSNNKYAASS YLSLTPEQWK SHRSYSCQVT HEGSTVEKTV APTECSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGLC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 5,229 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 5,229 nTPM
- spleen: 3,204 nTPM
- duodenum: 3,069 nTPM
- colon: 2,843 nTPM
- lymph node: 2,227 nTPM
- stomach: 2,197 nTPM
Single-cell type
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
- b-cells: 0 nCPM
Immune cell
- naive B-cell: 5,908 nTPM
- memory B-cell: 5,791 nTPM
- total PBMC: 906 nTPM
- classical monocyte: 7.8 nTPM
- neutrophil: 7.8 nTPM
- myeloid DC: 6 nTPM
Brain region
- cerebral cortex: 15 nTPM
- choroid plexus: 8.7 nTPM
- medulla oblongata: 5.6 nTPM
- white matter: 4.9 nTPM
- spinal cord: 3.9 nTPM
- thalamus: 3.4 nTPM
OntologyGO
Biological processes
- adaptive immune response
- B cell receptor signaling pathway
- immune response
- immunoglobulin mediated immune response
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGLC1 as an antibody target. Whether an autoantibody or antibody against IGLC1 could matter depends on whether native IGLC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGLC1 is annotated at the cell surface, where native IGLC1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IGLC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...